{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:30:34Z","timestamp":1760783434551,"version":"3.38.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.pscychresns.2011.03.004","type":"journal-article","created":{"date-parts":[[2011,8,14]],"date-time":"2011-08-14T18:48:38Z","timestamp":1313347718000},"page":"79-84","source":"Crossref","is-referenced-by-count":12,"title":["A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients"],"prefix":"10.1016","volume":"194","author":[{"given":"Anna","family":"Man\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Lome\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Javier","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Fernandez-Egea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Horga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Cot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Pavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pscychresns.2011.03.004_bb0005","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.schres.2008.08.025","article-title":"Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia","volume":"106","author":"Ballmaier","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00259-007-0621-0","article-title":"Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs","volume":"35","author":"Booij","year":"2008","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-9964(02)00526-1","article-title":"Caudate and putamen volumes in good and poor outcome patients with schizophrenia","volume":"64","author":"Buchsbaum","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0025","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-9964(02)00500-5","article-title":"Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine","volume":"65","author":"Drew","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0035","unstructured":"First, M. B., Spitzer R. S., Gibbon M., Williams J. B. W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV), Spanish adaptation. Masson, 1999."},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pscychresns.2006.10.002","article-title":"Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug","volume":"154","author":"Glenthoj","year":"2007","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0045","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1176\/ajp.155.12.1711","article-title":"Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia","volume":"155","author":"Gur","year":"1998","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00001756-199203000-00013","article-title":"Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism","volume":"3","author":"Hantraye","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1192\/bjp.178.6.506","article-title":"Recovery from psychotic illness: a 15- and 25-year international follow-up study","volume":"178","author":"Harrison","year":"2001","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0060","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(95)91801-9","article-title":"Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients","volume":"346","author":"Hietala","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0065","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1176\/appi.ajp.162.12.2233","article-title":"Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies","volume":"162","author":"Honea","year":"2005","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0070","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroimage.2005.07.051","article-title":"Dysfunction of ventral striatal reward prediction in schizophrenia","volume":"29","author":"Juckel","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0080","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00005053-199008000-00007","article-title":"The Positive and Negative Syndrome Scale\u2014Spanish adaptation","volume":"178","author":"Kay","year":"1990","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0085","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2006.01.023","article-title":"Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning","volume":"49","author":"Kellendonk","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0090","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1006\/nimg.2002.1296","article-title":"Voxel-based morphometric analysis of gray matter in first episode schizophrenia","volume":"17","author":"Kubicki","year":"2002","journal-title":"NeuroImage"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/appi.ajp.157.2.269","article-title":"Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography","volume":"157","author":"Laakso","year":"2000","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-9964(00)00095-5","article-title":"Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia","volume":"52","author":"Laakso","year":"2001","journal-title":"Schizophrenia Research"},{"issue":"93","key":"10.1016\/j.pscychresns.2011.03.004_bb0105","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"20","author":"Laruelle","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0006-3223(99)00257-7","article-title":"Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT","volume":"47","author":"Laruelle","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2004.03.053","article-title":"Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain","volume":"363","author":"Li","year":"2004","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00216006","article-title":"Provocative tests with psychostimulant drugs in schizophrenia","volume":"91","author":"Lieberman","year":"1987","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0893-133X(97)00045-6","article-title":"Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity","volume":"17","author":"Lieberman","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0006-3223(99)00109-2","article-title":"Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET","volume":"46","author":"Lindstrom","year":"1999","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pscychresns.2011.03.004_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/schbul\/sbp010","article-title":"Presynaptic regulation of dopamine transmission in schizophrenia","volume":"37","author":"Lyon","year":"2011","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.schres.2009.07.014","article-title":"Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM","volume":"114","author":"Man\u00e9","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0145","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-005-2250-2","article-title":"Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism","volume":"181","author":"Mateos","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0150","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00213-006-0570-5","article-title":"Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait","volume":"191","author":"Mateos","year":"2007","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nn804","article-title":"Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia","volume":"5","author":"Meyer-Lindenberg","year":"2002","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0160","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1073\/pnas.91.24.11651","article-title":"Elevated dopa decarboxylase activity in living brain of patients with psychosis","volume":"91","author":"Reith","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0165","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/0269881105056530","article-title":"The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1","volume":"19","author":"Schmitt","year":"2005","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0170","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-003-1700-y","article-title":"123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia","volume":"173","author":"Sj\u00f6holm","year":"2004","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pscychresns.2011.03.004_bb0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1176\/appi.ajgp.10.1.36","article-title":"Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries","volume":"10","author":"van Dyck","year":"2002","journal-title":"The American Journal of Geriatric Psychiatry"}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492711001132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492711001132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T16:20:16Z","timestamp":1741450816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492711001132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0925492711001132"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2011.03.004","relation":{},"ISSN":["0925-4927"],"issn-type":[{"type":"print","value":"0925-4927"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}